Patent classifications
C07C233/83
PROTEASOME INHIBITORS
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same
A compound with anti-drug resistant bacteria activity having the following formula ##STR00001##
(I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.
Pleuromutilin hippuric acid ester with antibacterial activity and a method of preparing the same
A compound with anti-drug resistant bacteria activity having the following formula ##STR00001##
(I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
PHARMACEUTICALLY ACCEPTABLE SALTS OF [3-(4- {2-BUTYL-1-[4-(4-CHLORO-PHENOXY)-PHENYL]-1H-IMIDAZOL-4-YL} -PHENOXY)-PROPYL]-DIETHYL-AMINE
The present invention relates to pharmaceutically acceptable salts of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine (COMPOUND I) useful in the treatment of RAGE mediated diseases.
PROTEASOME INHIBITORS
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
PROTEASOME INHIBITORS
The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.